Adam Bentvelzen

Adam Bentvelzen is a Senior Research Associate and Clinical Neuropsychologist currently at the Vascular Contributions to Dementia Centre of Research Excellence (VCD-CRE), Centre for Healthy Brain Ageing (CHeBA). He has worked at CHeBA since 2017 and his current research under the supervision of Scientia Professor Perminder Sachdev is focused on the international harmonisation of neuropsychological assessment and diagnostic criteria for vascular cognitive impairment and dementia (VCID). Dr Bentvelzen is also collaborating on other VCD-CRE projects including the development of a research clinic for monogenic causes of VCID (AusCADASIL), and validating the cognitive and biomarker profiles of “pure” cerebrovascular disease using neuropathologically-defined criteria. He is also investigating the validity of computerised neuropsychological methods, and trains and endorses UNSW research staff in paper-and-pencil and computerised neuropsychological assessment methods. Adam’s other research interests have included developing novel evidence-based resources to help clinicians detect dementia early and accurately, including the ADNeT Neuropsychological Norming Tool (ANNT), an online normative data calculator for a telephone cognitive screening tool (TICS-M), and the Dementia Outcomes Measurement Suite (DOMS), a collection of gold standard instruments for the assessment of persons with dementia. Dr Bentvelzen previously held a position as a Clinical Neuropsychologist at MQ Health Neuropsychology, Macquarie University Hospital Clinic (2017-2023) and has extensive clinical experience in the diagnosis and management of middle-aged to older adults with ageing-related neurocognitive disorders. dementia, alzheimer's disease, alzheimer dementia, neuropsychology, ageing, Clinical neuropsychology, Memory and attention, Psychology of ageing, Cognitive neuroscience, Geriatrics and gerontology